These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 24339285)

  • 21. Long-term follow-up of primary prophylactic implantable cardioverter-defibrillator therapy in Brugada syndrome.
    Sarkozy A; Boussy T; Kourgiannides G; Chierchia GB; Richter S; De Potter T; Geelen P; Wellens F; Spreeuwenberg MD; Brugada P
    Eur Heart J; 2007 Feb; 28(3):334-44. PubMed ID: 17251258
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Implantable cardioverter-defibrillator in Brugada syndrome: Long-term follow-up.
    El-Battrawy I; Roterberg G; Liebe V; Ansari U; Lang S; Zhou X; Borggrefe M; Akin I
    Clin Cardiol; 2019 Oct; 42(10):958-965. PubMed ID: 31441080
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term follow-up in patients with presumptive Brugada syndrome treated with implanted defibrillators.
    Steven D; Roberts-Thomson KC; Inada K; Seiler J; Koplan BA; Tedrow UB; Sweeney MO; Epstein LE; Stevenson WG
    J Cardiovasc Electrophysiol; 2011 Oct; 22(10):1115-9. PubMed ID: 21545364
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictors of inappropriate shock in Brugada syndrome patients with a subcutaneous implantable cardiac defibrillator.
    Casu G; Silva E; Bisbal F; Viola G; Merella P; Lorenzoni G; Motta G; Bandino S; Berne P
    J Cardiovasc Electrophysiol; 2021 Jun; 32(6):1704-1711. PubMed ID: 33928706
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcome after implantable cardioverter-defibrillator in patients with Brugada syndrome: the Gulf Brugada syndrome registry.
    Daoulah A; Alsheikh-Ali AA; Ocheltree AH; Ocheltree S; Al-Kaabi S; Malik M; Al-Habib AK; Hamed A; Al-Rawahi N; Al-Sayegh A; Al-Hasaniah S; Ul-Haq E
    J Electrocardiol; 2012; 45(3):327-32. PubMed ID: 22074744
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Arrhythmic Events in Brugada Syndrome: A Nationwide Israeli Survey of the Clinical Characteristics, Treatment; and Long-Term Follow-up (ISRABRU-VF).
    Leshem E; Rahkovich M; Mazo A; Suleiman M; Blich M; Laish-Farkash A; Konstantino Y; Fogelman R; Strasberg B; Geist M; Chetboun I; Swissa M; Ilan M; Glick A; Michowitz Y; Rosso R; Glikson M; Belhassen B
    Isr Med Assoc J; 2018 May; 20(5):269-276. PubMed ID: 29761670
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term complications of implantable defibrillator therapy in Brugada syndrome.
    Miyazaki S; Uchiyama T; Komatsu Y; Taniguchi H; Kusa S; Nakamura H; Hachiya H; Isobe M; Hirao K; Iesaka Y
    Am J Cardiol; 2013 May; 111(10):1448-51. PubMed ID: 23433764
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of SMART Pass filter in patients with ajmaline-induced Brugada syndrome and subcutaneous implantable cardioverter-defibrillator eligibility failure: results from a prospective multicentre study.
    Conte G; Cattaneo F; de Asmundis C; Berne P; Vicentini A; Namdar M; Scalone A; Klersy C; Caputo ML; Demarchi A; Özkartal T; Salghetti F; Casu G; Passarelli I; Mameli S; Shah D; Burri H; De Ferrari G; Brugada P; Auricchio A
    Europace; 2022 May; 24(5):845-854. PubMed ID: 34499723
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Electrophysiological Study Prognostic Value and Long-Term Outcome in Drug-Induced Type 1 Brugada Syndrome: The IBRYD Study.
    Russo V; Pafundi PC; Caturano A; Dendramis G; Ghidini AO; Santobuono VE; Sciarra L; Notarstefano P; Rucco MA; Attena E; Floris R; Romeo E; Sarubbi B; Nigro G; D'Onofrio A; Calò L; Nesti M
    JACC Clin Electrophysiol; 2021 Oct; 7(10):1264-1273. PubMed ID: 33933405
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictors of Ventricular Arrhythmias and Sudden Death in a Québec Cohort With Brugada Syndrome.
    Rivard L; Roux A; Nault I; Champagne J; Roux JF; Tadros R; Talajic M; Cadrin-Tourigny J; Shohoudi A; Mondésert B; Roy D; Macle L; Andrade J; Dyrda K; Dubuc M; Guerra PG; Sarrazin JF; Thibault B; Khairy P
    Can J Cardiol; 2016 Nov; 32(11):1355.e1-1355.e7. PubMed ID: 27378596
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevention of inappropriate ICD shocks in patients with Brugada syndrome.
    Veltmann C; Kuschyk J; Schimpf R; Streitner F; Schoene N; Borggrefe M; Wolpert C
    Clin Res Cardiol; 2010 Jan; 99(1):37-44. PubMed ID: 19760052
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Long-term outcome after cardioverter-defibrillator implantation in patients with Brugada syndrome].
    Binbin Y; Jingping L; Bing Y; Minglong C; Jiangang Z; Kejiang C; Qijun S
    Zhonghua Xin Xue Guan Bing Za Zhi; 2015 Aug; 43(8):690-4. PubMed ID: 26955725
    [TBL] [Abstract][Full Text] [Related]  

  • 33. T-wave oversensing in patients with Brugada syndrome: true bipolar versus integrated bipolar implantable cardioverter defibrillator leads: multicenter retrospective study.
    Rodríguez-Mañero M; de Asmundis C; Sacher F; Arbelo E; Probst V; Castro-Hevia J; Maury P; Rollin A; Lambiase P; García-Bolao I; Chierchia GB; Fukushima Kusano K; Gourraud JB; Schilling R; Kamakura T; Martínez-Sande JL; Haïssaguerre M; González-Juanatey JR; Brugada J; Brugada P
    Circ Arrhythm Electrophysiol; 2015 Aug; 8(4):792-8. PubMed ID: 26041387
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low disease prevalence and inappropriate implantable cardioverter defibrillator shock rate in Brugada syndrome: a nationwide study.
    Holst AG; Jensen HK; Eschen O; Henriksen FL; Kanters J; Bundgaard H; Svendsen JH; Haunsø S; Tfelt-Hansen J
    Europace; 2012 Jul; 14(7):1025-9. PubMed ID: 22286273
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Asymptomatic Brugada Syndrome: Clinical Characterization and Long-Term Prognosis.
    Sieira J; Ciconte G; Conte G; Chierchia GB; de Asmundis C; Baltogiannis G; Di Giovanni G; Saitoh Y; Irfan G; Casado-Arroyo R; Julià J; La Meir M; Wellens F; Wauters K; Pappaert G; Brugada P
    Circ Arrhythm Electrophysiol; 2015 Oct; 8(5):1144-50. PubMed ID: 26215662
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outcomes of defibrillator therapy in catecholaminergic polymorphic ventricular tachycardia.
    Roses-Noguer F; Jarman JW; Clague JR; Till J
    Heart Rhythm; 2014 Jan; 11(1):58-66. PubMed ID: 24120999
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outcomes in Brugada Syndrome Patients With Implantable Cardioverter-Defibrillators: Insights From the SGLT2 Registry.
    Lee S; Li KHC; Zhou J; Leung KSK; Lai RWC; Li G; Liu T; Letsas KP; Mok NS; Zhang Q; Tse G
    Front Physiol; 2020; 11():204. PubMed ID: 32210841
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A score model to predict risk of events in patients with Brugada Syndrome.
    Sieira J; Conte G; Ciconte G; Chierchia GB; Casado-Arroyo R; Baltogiannis G; Di Giovanni G; Saitoh Y; Juliá J; Mugnai G; La Meir M; Wellens F; Czapla J; Pappaert G; de Asmundis C; Brugada P
    Eur Heart J; 2017 Jun; 38(22):1756-1763. PubMed ID: 28379344
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Brugada syndrome in Canada: a unique French-Canadian experience.
    Champagne J; Philippon F; Gilbert M; Molin F; Blier L; Nault I; Sarrazin JF; Charbonneau L; Dufort L; Drolet B; Chahine M; O'Hara GE
    Can J Cardiol; 2007 Oct; 23 Suppl B(Suppl B):71B-75B. PubMed ID: 17932591
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Near fatal ventricular fibrillation in Brugada syndrome despite presence of an implanted implantable cardioverter defibrillator.
    Belhassen B; Viskin S
    Can J Cardiol; 2014 Nov; 30(11):1460.e3-5. PubMed ID: 25240706
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.